Annual Results Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 5.57% vs -0.11% in Mar 2024
Standalone Net Profit
YoY Growth in year ended Mar 2025 is -7.86% vs 27.98% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -14.55% vs 25.32% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -27.27% vs -15.38% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Compare Annual Results Of Par Drugs & Che. With
Figures in Cr
Standalone Annual Results
Change(INR)
Change(%)
Net Sales
100.97
88.16
12.81
14.53%
Other Operating Income
0.00
0.00
0.00
Total Operating income
100.97
88.16
12.81
14.53%
Raw Material Cost
39.41
80.93
-41.52
-51.30%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-1.28
-4.11
2.83
68.86%
Employee Cost
5.85
2.12
3.73
175.94%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.01
-0.01
-100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
37.49
6.71
30.78
458.72%
Total Expenditure (Excl Depreciation)
81.47
85.66
-4.19
-4.89%
Operating Profit (PBDIT) excl Other Income
19.50
2.50
17.00
680.00%
Other Income
2.15
2.62
-0.47
-17.94%
Operating Profit (PBDIT)
21.65
5.12
16.53
322.85%
Interest
0.08
1.29
-1.21
-93.80%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
21.57
3.83
17.74
463.19%
Depreciation
3.65
0.30
3.35
1,116.67%
Profit Before Tax
17.92
3.53
14.39
407.65%
Tax
4.57
0.99
3.58
361.62%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
13.36
2.53
10.83
428.06%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
13.36
2.53
10.83
428.06%
Equity Capital
12.30
8.12
4.18
51.48%
Face Value
10.00
10.00
0.00
Reserves
86.67
27.57
59.10
214.36%
Earnings per share (EPS)
10.86
3.12
7.74
248.08%
Diluted Earnings per share
10.86
3.12
7.74
248.08%
Operating Profit Margin (Excl OI)
19.31%
2.84%
0.00
16.47%
Gross Profit Margin
21.36%
4.34%
0.00
17.02%
PAT Margin
13.23%
2.87%
0.00
10.36%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 100.97 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 5.57% vs -0.11% in Mar 2024
Annual - Standalone Net Profit
Standalone Net Profit 13.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.86% vs 27.98% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 19.50 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -14.55% vs 25.32% in Mar 2024
Annual - Interest
Interest 0.08 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -27.27% vs -15.38% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.31%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
